abstract |
A nasal formulation includes a liquid carrier to be introduced into upper airways through a nasal cavity. Present in the liquid carrier are low molecular weight arginine-rich peptides derived from protamine. When introduced into the upper airways, the low molecular weight arginine-rich peptides are to increase nitric oxide (NO) levels in the upper airways. The nasal formulation has a pH ranging from 4 to 10. |